Alzheimer's Research Fraud

A recent investigation has uncovered significant fraud in Alzheimer's research, particularly concerning the amyloid beta hypothesis. Despite treatments targeting amyloid beta, patients continue to experience disease progression, raising questions about the validity of past studies. The discussion highlights the alarming reproducibility crisis in scientific research, where a staggering 70% of studies fail to be replicated, casting doubt on the integrity of findings in the field.